Provention Bio, Inc.

PRVB · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$44,039$78,190$102,294$39,165
Short-Term Investments$120,964$16,921$19,530$46,208
Receivables$1,359$0$0$0
Inventory$1,231$0$0$0
Other Curr. Assets$7,056$5,985$4,730$623
Total Curr. Assets$174,649$101,096$126,554$85,996
Property Plant & Equip (Net)$2,526$2,384$1,845$0
Goodwill$0$0$0$0
Intangibles$59,561$0$0$0
Long-Term Investments$0$32,021$0$0
Tax Assets$0$0$0$0
Other NC Assets$120$120$120$0
Total NC Assets$62,207$34,525$1,965$0
Other Assets$0$0$0$623
Total Assets$236,856$135,621$128,519-$75,221
Liabilities
Payables$6,761$3,546$7,568$1,775
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$17,686$5,599$0$0
Other Curr. Liab.$65,943$13,646$9,162$2,065
Total Curr. Liab.$90,390$22,791$16,730$3,840
LT Debt$23,910$590$715$0
Deferred Rev, NC$707$1,506$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$24,617$2,096$715$0
Other Liabilities$0$0$288,716$0
Cap. Leases$0$0$0$0
Total Liabilities$115,007$24,887$306,161$3,840
Equity
Pref Stock$0$0$0$85,996
Common Stock$9$6$6$5
Retained Earnings-$405,639-$292,074-$177,642-$79,061
AOCI-$647-$139-$15-$85,996
Other Equity$528,126$133$9$85,991
Total Equity$121,849-$292,074-$177,642-$79,061
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$236,856-$267,187$128,519-$75,221
Net Debt-$20,129-$77,600-$101,579-$39,165